LUDY LLASUS: Open Payments
NPI 1073709424 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 4 payments from 4 companies in 2025. Trend: 2023 $288 · 2024 $197 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
| Novo Nordisk Inc | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: REXULTI, Ozempic, ZORYVE, AIRSUPRA.
Industry payments across NV — which companies pay providers there.
